Fertility solutions Kenya

Fertility solutions Kenya IVF and infertility management services , championing for affordable and high quality IUI/IVF services with great passion and concern to the clients, in Kenya.

We deliver quality care in a courteous, respectful & professional manner.

13/02/2026

Major topics in In Vitro Fertilization (IVF) range from the clinical stages of the procedure to the complex medical and ethical factors that influence its success.
1. The IVF Process (Core Steps)
A standard IVF cycle typically takes 4–6 weeks and involves several distinct clinical stages:
• Ovarian Stimulation: Injectable hormone medications (such as FSH and LH) are used for 8–14 days to encourage the ovaries to produce multiple mature eggs instead of the usual one.
• Egg Retrieval: A minor surgical procedure performed under sedation where a needle, guided by ultrasound, is used to collect mature eggs from ovarian follicles.
• Fertilization: Eggs are combined with s***m in a laboratory. This can occur via Conventional Insemination (mixing in a dish) or ICSI (Intracytoplasmic S***m Injection), where a single s***m is injected directly into an egg.
• Embryo Culture: Fertilized eggs are grown for 2–6 days until they reach the blastocyst stage.
• Embryo Transfer: One or more embryos are placed into the uterus using a thin catheter.
2. Success Factors and Predictors
Success rates vary significantly based on individual biological and lifestyle factors:
• Age: The most critical factor; live birth rates are significantly higher for individuals under 35 (approx. 50%+) and decline sharply after age 40 (approx. 8% or lower).
• Ovarian Reserve: Measured by tests like AMH (Anti-Müllerian Hormone) levels and antral follicle counts to predict how well the body will respond to stimulation.
• Lifestyle Factors: Smoking, obesity (BMI >30), and excessive caffeine or alcohol intake can reduce success rates by up to 50%.
3. Medical Indications and Specialized Techniques
IVF is used to address various fertility challenges and family-building needs:
• Medical Conditions: Blocked fallopian tubes, endometriosis, polycystic o***y syndrome (PCOS), and male factor infertility (low s***m count/motility).
• Genetic Screening (PGT): Preimplantation Genetic Testing allows embryos to be screened for chromosomal abnormalities or specific inherited diseases (e.g., cystic fibrosis, sickle cell anemia) before transfer.
• Third-Party Reproduction: Use of donor eggs, donor s***m, or gestational carriers for individuals without a functional uterus or for LGBTQIA+ family building.

4. Risks and Side Effects
• Short-term Effects: Bloating, cramping, mood swings, and bruising at injection sites.
• Ovarian Hyperstimulation Syndrome (OHSS): A rare but serious complication where ovaries become swollen and painful due to over-response to medication.
• Pregnancy Risks: Increased likelihood of multiple births (if multiple embryos are transferred), premature delivery, and a slightly higher risk of certain birth defects.
5. Financial and Emotional Impact
• Cost: IVF is often expensive, with self-pay cycles frequently costing $15,000 to $30,000 including medications.
• Psychological Toll: The process is emotionally demanding; many clinics offer counseling to help patients manage the stress, anxiety, and potential for negative results.

OTHERS SERVICES

1. PGT (Pre-implantation genetic testing)
Pre-implantation genetic testing (PGT) is a specialized laboratory procedure performed on embryos created through In Vitro Fertilization (IVF) to identify genetic or chromosomal abnormalities before implantation. This allows physicians to select embryos with the highest health potential, reducing the risk of miscarriages, failed transfers, or the birth of a child with a serious genetic condition.
Three Main Types of PGT
Current clinical standards categorize PGT into three primary types:
• PGT-A (Aneuploidy Screening): Screens for an abnormal number of chromosomes (extra or missing), such as in Down Syndrome (Trisomy 21). It is often used for patients of advanced maternal age (over 35), those with recurrent miscarriages, or multiple failed IVF cycles.
• PGT-M (Monogenic/Single Gene Disorders): Specifically tests for inherited diseases caused by a single gene mutation, such as Cystic Fibrosis, Sickle Cell Anemia, Huntington’s Disease, or Spinal Muscular Atrophy.
• PGT-SR (Structural Rearrangements): Used when one or both parents have a balanced chromosomal rearrangement (like translocations or inversions), which increases the risk of producing embryos with unbalanced chromosomal material.

The Procedure
The process occurs within an IVF cycle and typically follows these steps:
1. Ovarian Stimulation and Egg Retrieval: Hormones stimulate the ovaries to produce multiple eggs, which are then surgically retrieved.
2. Fertilization: Eggs are fertilized using IVF or ICSI (Intracytoplasmic S***m Injection).
3. Embryo Culture: Embryos are grown in the lab for 5–6 days until they reach the blastocyst stage (approx. 100–150 cells).
4. Embryo Biopsy: A highly trained embryologist removes a small number of cells (typically 5–10) from the trophectoderm, the outer layer that will form the placenta. The inner cell mass, which develops into the fetus, remains undisturbed.
5. Genetic Analysis and Freezing: While the embryos are frozen (vitrified), the removed cells are sent to a genetic laboratory for analysis (often using Next Generation Sequencing).
6. Transfer: Only embryos identified as healthy or unaffected are selected for transfer to the uterus in a subsequent frozen embryo transfer (FET) cycle.

Key Benefits and Risks
Benefits Risks and Limitations
Higher Success Rates: Improves clinical pregnancy rates per transfer, especially for older patients. Embryo Damage: A small risk (approx. 0.1%–5%) that the biopsy or freeze/thaw process could damage the embryo.
Reduced Miscarriage: Selection of chromosomally normal embryos significantly lowers the risk of early pregnancy loss. Inaccuracy/Mosaicism: Mosaic embryos (containing both normal and abnormal cells) can lead to false positives or negatives, potentially resulting in the discarding of viable embryos.
Disease Prevention: Prevents transmission of known family genetic disorders without needing a late-pregnancy termination. No Transfer: There is a risk that all embryos from a cycle may test abnormal, resulting in no embryo being available for transfer.
Single Embryo Transfer: Facilitates transferring only one healthy embryo, avoiding the risks of multiple pregnancies (twins/triplets).

Cost: PGT typically adds $3,000–$6,000+ to the cost of an IVF cycle and is often not covered by standard insurance.
Regulation and Ethics
• Medical Oversight: In the UK, the Human Fertilisation and Embryology Authority (HFEA) strictly regulates which conditions are licensed for testing.
• Ethical Debate: Concerns exist regarding "designer babies" and the selection of non-medical traits like s*x, which is prohibited for "family balancing" in many regions, including the UK.
• Genetic Counseling: Professional genetic counseling is strongly recommended before proceeding to understand the statistics, limitations, and personal implications of the results

2. Egg and s***m donations in fertility treatments
Egg and s***m donation are key components of assisted reproductive technology (ART), allowing individuals and couples to achieve pregnancy when they cannot use their own genetic material due to medical or social reasons.
Core Processes in IVF Donation
• Egg Donation: A female donor undergoes ovarian stimulation with hormonal medications for approximately 10–14 days. Multiple mature eggs are then retrieved through a minor surgical procedure called transvaginal ultrasound aspiration under sedation.
• S***m Donation: A male donor provides a semen sample, usually through ej*******on at a clinic or bank. The sample is "washed" to concentrate healthy, motile s***m for fertilization.
• Double Donation: Involves using both a donor egg and donor s***m, meaning the child will have no genetic link to either intended parent.
• Fertilization & Transfer: In the lab, donor eggs are fertilized with s***m using standard IVF or Intracytoplasmic S***m Injection (ICSI), where a single s***m is injected into an egg. Resulting embryos are cultured for 3–6 days before one or two are transferred into the recipient's prepared uterus.
Who Benefits from Donation?
• Women: Those with low ovarian reserve, premature ovarian failure,premature ovarian insufficiency, advanced maternal age (typically over 40-42), or genetic disorders.
• Men: Those with severe male factor infertility (e.g., zero s***m count or poor quality).
• Social Reasons: Single women, same-s*x couples, and individuals using gestational surrogates.
Screening and Regulations
• Medical & Genetic Testing: Donors must undergo rigorous screening for infectious diseases (HIV, Hepatitis, STIs) and genetic conditions like cystic fibrosis.
• Psychological Counseling: This is often mandatory to ensure donors and recipients understand the emotional and ethical implications of third-party reproduction.
• Legal Protections: In most jurisdictions, donors have no legal rights or financial obligations to children born from their donation. Birth certificates typically name the intended parents as the legal parents.
Key Considerations
• Success Rates: Donation cycles generally have higher success rates (often 50–70% pregnancy rate per transfer) because they use high-quality gametes from young, healthy donors.
• Fresh vs. Frozen:
o Fresh: Requires synchronizing the donor’s and recipient’s menstrual cycles using hormonal medication.
o Frozen: Allows for more flexible timing and immediate start, as gametes are already stored in banks.
• Costs: These treatments are more expensive than standard IVF due to donor compensation and additional lab processing.
o Kenya: Approximately 150,000 – 200,000 KES for local donor egg IVF and approximately over Kes 500,000 for Caucasian donor egg.
o Also for international egg donors like south Sudanese, Ethiopian among others are equally expensive.
o More over, some local egg or s***ms donor are expensive especially somali or any other muslim donors which are considered Haram – forbidden in Islamic religion. In those exceptional cases the recipient is likely accompanied or look for his/her own donor.

3. Surrogacy services and laws governing
Surrogacy services and laws vary significantly by jurisdiction, ranging from well-regulated frameworks to "legal vacuums" where procedures rely on private contracts.
Surrogacy Laws by Region (2026 Status)
As of 2026, the global legal landscape for surrogacy is categorized into three main frameworks:
• Regulated & Inclusive (e.g., Kenya): In early 2025, implemented updated guidelines under the Assisted Reproductive Technology (ART) Bill.
o Limits: Surrogates are restricted to three lifetime pregnancies with a mandatory two-year recovery period between each.
o Rights: Intended parents (including singles and same-s*x couples) can seek surrogacy, though same-s*x couples often proceed as "single parents" due to broader cultural and legal nuances.
o Parentage: Intended parents must typically apply for a court order or adoption after birth to be recognized as legal parents.
• Altruistic Only (e.g., UK, India):
o United Kingdom: Governed by the Surrogacy Arrangements Act 1985 and Human Fertilisation and Embryology Act 2008. Commercial surrogacy is illegal; only "reasonable expenses" are reimbursed (typically £10,000–£15,000).
o India: The Surrogacy (Regulation) Act, 2021 bans commercial surrogacy, allowing only altruistic arrangements for Indian married couples with a close relative as the surrogate.
• Varied State-Level (United States):
o Commercial Friendly: have clear statutes permitting compensated gestational surrogacy and allowing pre-birth parentage orders.
o Restrictive: have recently updated their laws (2024/2025) to provide clearer pathways but often maintain strict "Surrogate's Bill of Rights".

Essential Surrogacy Services
Most professional surrogacy journeys involve these core services provided by agencies or fertility clinics:
1. Screening & Matching: Comprehensive medical and psychological evaluations for both surrogates and intended parents.
2. Legal Counseling: Drafting binding surrogacy agreements that define parental rights, financial compensation, and medical responsibilities.
3. IVF & Medical Support: The medical process of creating embryos (using the intended parents' or donors' gametes) and transferring them to the surrogate's uterus.
4. Pregnancy Management: Routine prenatal care, psychological counseling, and logistical support through delivery.
5. Post-Birth Legalization: Navigating court orders (parental orders) or adoption processes to ensure the intended parents are the only ones on the child's birth certificate.

Key Costs and Requirements For Surrogacy Services
• Typical Costs (2026): Kenya
offers full programs for roughly Kes 3.5 million to Kes 5 Million , which is 60–80% cheaper than the U.S. or Europe. This cover for surrogates compensation and her upkeep, medicines , antenatal care and delivery, legal fees, embryos preservation and medical fees.
• Surrogate Eligibility: Most reputable programs require surrogates to be aged 21–40, have at least one child of their own, and pass rigorous infectious disease and psychological screenings.

Major Reasons behind doing IVF treatment
Male infertility often stems from s***m issues (count, motility, shape) or blockages, while female infertility frequently involves ovulation problems (PCOS, hormone imbalance), blocked fallopian tubes, endometriosis, or uterine issues; both s*xes are affected by age, weight, STIs, lifestyle (smoking, alcohol), and environmental factors, with underlying health conditions also playing a role.
Causes of Male Infertility
• S***m Problems: Low count, poor movement (motility), abnormal shape, or genetic issues.
• Blockages: Obstructions in the reproductive tract (e.g., from infection or injury) prevent s***m from reaching semen. Blockages in the tubes that transport s***m, which can be congenital or caused by injury or infection.
• Hormonal Issues: Imbalances affecting s***m production. Low testosterone (hypogonadism) or disorders of the pituitary gland.
• Varicocele: Enlarged veins in the sc***um that can affect s***m quality. Swollen veins in the sc***um that increase testicular temperature, harming s***m production.
• Infections: STIs (chlamydia, gonorrhea) or mumps.
• Environmental Factors: Exposure to heat, pesticides, heavy metals, or certain medicines.
• Lifestyle: Smoking, excessive alcohol, drug use, obesity, or being underweight.
• Retrograde Ej*******on: Semen enters the bladder during or**sm instead of emerging from the p***s.
• Genetic Factors: Inherited conditions like Klinefelter syndrome (an extra X chromosome) or cystic fibrosis.
Causes of Female Infertility
• Ovulation Disorders: Irregular or absent ovulation due to PCOS, thyroid issues, or high prolactin levels.
• Blocked Fallopian Tubes: Often from pelvic inflammatory disease (PID), infections like chlamydia and gonorrhea, endometriosis, or surgery, preventing egg-s***m meeting.
• Endometriosis: Uterine tissue growing outside the uterus, causing scarring and inflammation.
• Uterine/Cervical Issues: Fibroids, polyps, or problems with cervical mucus.
• Age: Egg quality and quantity decline, especially after 37.
• Hormonal Imbalances: Affecting ovulation. Problems with the thyroid or pituitary glands that disrupt reproductive hormones.
• STIs: Chlamydia and gonorrhea can cause tubal damage.
• Lifestyle: Smoking, extreme weight (under/over), excessive exercise, alcohol.
• Primary Ovarian Insufficiency (POI): Early loss of eggs or ovarian function before age 40.

Shared Factors
• Age: Affects both s*xes, though more significantly for women.
• Body Weight: Both obesity and being underweight. This disrupt hormonal balance
• Lifestyle issues; Smoking & Alcohol: Negative impact on both partners' fertility.
• Cancer Treatments: Chemotherapy/radiation can impair fertility.
• Chronic Diseases: Diabetes, kidney disease, or untreated STIs
• Environmental Exposure: Prolonged exposure to high heat (e.g., hot tubs), pesticides, lead, or radiation

Footnotes

1) Always recommend to your patients for Laser Assisted Hatching(LAH) and
Embryo glueing as extra services at NO extra Costs, this is a secrets to increase the chances
of implantation and pregnancy rates.

2) Not all IVF centers offers above services. Contacts us for information.
3) Where AMH levels are low(diminished/low ovarian reserve), you can recommend platelet rich plasma(PRP) for ovarian rejuvenation before making decision for egg donation program. Likewise for obstructive azoos***mia, recommended testicular s***m aspiration(TESA) before s***m donation program. We always try to give couples an opportunity to have their biological children.
4) insurances and corporate covering IVF treatment in Kenya ; Department of Defence, Kenya seeds, Safaricom, KRA, GDC(Geothermal devt corp), Kenya pipeline, Kengen, NIS, TSC, KPLC,Safaricom,Bupa global, Aetna, Judiciary,Nairobi bottlers, TSC secretariat, Kenya seeds, First Assurance, KCB. Other local insurance companies require pre-authorization for IVF


FERTILITY SOLUTIONS KENYA
0736 024 638 / 0726 683 108
YOUR FERTILITY PARTNER
For Professional and high success rates IUI/IVF- ICSI-IMSI
Treatment with courtesy and compassion

Call now to connect with business.

13/02/2026

OligoAsthenoTeratozoos***mia
OligoAsthenoteratozoos***mia is one of the male infertility conditions in which a man produces low s***m count with low motility and poor morphology. it’s a combination of three conditions related to male infertility.
• Asthenozoos***mia – impaired s***m motility
• Teratozoos***mia – abnormal s***m morphology
• Oligozoos***mia – low s***m count
• S***matogonia – immature s***m cells
Put them together, and you have oligoasthenoteratozoos***mia, a complex syndrome that is, however, quite treatable.




Teratozoos***mia treatment varies based on the severity of the condition and the couple’s overall health. In some cases, lifestyle changes can improve s***m morphology, while in others, assisted reproductive technology (ART) is recommended
Motility is the term that specifies the ability of the s***m to move forward quickly and in a straight line; it is a vital component for natural conception. The reduction in s***m motility decreases the chances of successful fertilisation of eggs in the female reproductive tract.

Asthenoteratozoos***mia condition can be easily diagnosed with the help of a sinogram, and after the root cause diagnosis, Asthenoteratozoos***mia treatment can be started.
Asthenoteratozoos***mia includes the word aesthetic, which means weak, and it is a condition where s***ms have reduced motility compared to healthy ones. It is a condition when the s***m is unable to move quickly and efficiently inside a woman’s body, which is a vital aspect of reaching the egg and leading to fertilisation and pregnancy. The s***m needs to have at least 25 micrometres per second of progressive motility to get through the cervical mucus to fertilise a woman’s egg.

Types of s***m motility issues:
• Slow or sluggish progressive motility – where s***m move linearly
• Non-Progressive motility – when s***ms move sluggishly and go round and round in the same place
• No motility- very sluggish
NB; A man does not suffer from Asthenoteratozoos***mia when he has equal to or more than 40 percent of motile s***m and progressive motility values above 32 percent. There are diverse causes of Asthenoteratozoos***mia that affect s***m motility.

CAUSES ASTHENOZOOSPERMIA
• Asthenozoos***mia causes are often multifactorial, involving lifestyle factors, genetic predispositions, or underlying medical conditions.
• Some common culprits include unhealthy lifestyle habits like smoking, excessive alcohol consumption, and drug use. Medical conditions such as diabetes, prostate infections, varicoceles, and hormonal imbalances can also play a role.
• Inflammation: If a male has any inflammation in the s***m duct, prostate gland, or any other reproductive organ, then it can lead to Asthenoteratozoos***mia. These diseases directly affect your s***m count and s***m motility, reducing the speed of s***m and its ability to fertilise the eggs.
• Varicocele: It is a condition of enlarged scrotal veins, one of the leading causes of Asthenoteratozoos***mia.
• Abnormal semen liquefaction: It is a condition that reduces spaces inside s***m ducts and obstructs the movements along with the s***m activities.
• Abnormalities in chromosomes: It is a condition in which you have abnormalities in s*x chromosomes, and thus, it affects your s***m count and motility. It is considered as one of the male infertility symptoms.
• Immunological components: There are many antibodies that disrupt the movements of s***ms in multiple ways. Many studies show the presence of these anti-s***m antibodies on the tails of s***ms that become barriers to fertilising the egg.
• Lifestyle factors: Many unhealthy lifestyle habits and diets are the great reasons for your low s***m motility. It includes regular smoking, alcohol, lack of exercise, and usage of drugs that reduce testosterone levels.
• The leading cause of Asthenoteratozoos***mia is low s***m motility. The condition develops if the percentage of motile s***m after ej*******on is below 40. However, to achieve a successful pregnancy, it is best to consult the best IVF specialist, as they may help you fulfil your dreams and recommend the best treatment options for male infertility.

OligoAsthenoTeratozoos***mia Diagnosis
As per WHO, if the total percentage of all types of s***m motility is less than 40, the male will be diagnosed with a condition called Asthenoteratozoos***mia. Low motility will suggest that s***m may not be able to fertilise the eggs in normal circumstances, and assisted reproductive technology will be needed. While determining the s***m for Asthenoteratozoos***mia, many other factors are also evaluated to confirm the condition, like colour, quality, pH, and consistency of semen. Also, the presence of immature s***m, the shape of s***m, and count are also evaluated. During the process of fertilisation, s***m motility is essential as the ej******ed s***m needs to pe*****te the cervical mucus to reach the uterus and then the fallopian tube, in which the egg is waiting.
• Couple history trying to conceive- duration ,frequency, lifestyle, ejaculatory problems etc.
• Blood tests- determine the cause of infertility and overall heath
• Genetic tests- check for abnormal genes which may alter s***ms parameters
• Semen analysis which may also show if there is increased numbers of leucocytes which may interfere with motility and functions.
• S***matic venography- check the position of veins in sc***um. A dye is put in the body and Xray is done to check varicocele
• Scrotal ultrasound- used to find lumps and other changes in the te**is and sc***um.

OligoAsthenoteratozoos***mia treatment option

The treatment of the condition depends upon its root cause. Medications can treat the presence of bacteria.

In some cases, varicocele correction requires surgery that helps improve s***m motility. Lifestyle changes can also help to manage s***m health. Thus, as per specialists, treatment depends upon the extent of the condition. There are assisted reproduction methods where healthy s***ms are selected and used to fertilise an egg using specific external techniques and tools. These methods are used to correct the inability of s***m to travel on its own. IVF, also known as In Vitro Fertilisation, is a very successful treatment method when done by an experienced IVF specialist. Pride IVF is among the best IVF clinics, using the most upgraded form of technology in the field of medical sciences and offering the most affordable fertility services and the most experienced infertility specialist.

Study 1 : Causes Of OAT
Men with oligoasthenoteratozoos***mia harbour higher numbers of multiple mitochondrial DNA deletions in their s***matozoa, but individual deletions are not indicative of overall aetiology

It is believed that one cause of s***m dysfunction might arise through multiple mitochondrial DNA deletions mtDNA resulting in the formation of an incomplete electron transport chain. This study investigates the incidence of multiple mtDNA in human s***matozoa prepared on Percoll gradients, also further analyses the incidence of one other deletion, the 15 bp deletion in the cytochrome c oxidase subunit III (COX III) of complex IV to determine whether other deletions flanked by direct repeats could be equally predictive. The incidence of these three deletions is not clearly associated with the diagnostic categorization of male infertility. However, the use of long PCR showed that samples harbouring high numbers of mtDNA is associated with the diagnostic categorization of male infertility.
Thereby these deletions could arise through a free radical-driven event occurring at the s***matogonial cell stage resulting in the replication of mtDNA molecules at the expense of wild-type molecules. These anomalies in ej******ed s***m mtDNA account for reproductive failure in some men.

Background
Mitochondria are the cell's major source of oxidative energy through their production of ATP. ATP is produced by the transfer of electrons along the electron transfer chain (ETC) and the subsequent reduction of oxygen to water. Mitochondria possess several copies of their own genome, each encoding for 13 of the proteins required for the ETC. Each mitochondrion or cell can be either homoplasmic (all wild-type or all mutated/deleted), or heteroplasmic (a combination of both wild-type and mutated/deleted).
Deletions in mtDNA (ΔmtDNA) are `common' to many post-mitotic cell types. In particular, the 4977 bp deletion found in a number of tissues, e.g. brain, liver, heart has been described as the `common' deletion. This `common' deletion, like the 7.4 kb deletion (another frequently analysed deletion) is flanked by direct repeats. It has been proposed that this characteristic of flanking direct repeats could result in polymerase misreading, large scale deletion of the mitochondrial genome and the loss of several vital genes. In many instances, these frequently analysed mtDNA have been analysed individually through conventional polymerase chain reaction (PCR) to assess the overall level of multiple deletions present in various tissues.

To date, several studies have investigated the relationship between multiple mtDNA and s***m dysfunction. Two studies analysing the 4977 bp `common' deletion appeared to produce conflicting data: in one of these studies, a negative correlation was observed between the level of the 4977 bp deletion and the degree of motility in separated s***m populations (Kao et al., 1995). The other study analysed semen samples and found no correlation with patient pathology (Cummins et al., 1998).

Long PCR is a modification of conventional PCR and can amplify all or part of the whole mitochondrial genome. This allows detection of both wild-type and multiple somatic ΔmtDNA from one sample within one reaction. In one study, a male patient with Kearns–Sayre syndrome (a debilitating mtDNA neuropathy), presented with oligozoos***mia and long PCR analysis confirmed the presence of multiple deletions in his s***matozoa. More studies demonstrated that the number of multiple somatic mtDNA in men with oligoasthenozoos***mia was higher than those of the fertile males. However, none of the above mentioned studies has specifically extracted leukocytes and, consequently, because leukocytes are fast replicating cells that favour replication of wild-type molecules at the expense of deleted molecules a mixed population of s***matozoa and leukocytes were analysed. Indeed, 90% of infertile men have leukocytes in their ej*****te (mean 133×103/ml. Therefore, in the interests of accuracy in any analysis of s***m mtDNA, it is vital that leukocytes are removed.

This study investigates the impact that multiple mtDNA have on s***m quality. First, it analyse the presence of the 4977 and 7.4 kb deletions in both the high and low density Percoll fractions of s***matozoa from different patients, in order to determine whether these frequently analysed deletions are more prevalent in poor quality than in better quality s***matozoa. Second, it also analyse for the presence of the 15 bp deletion in the cytochrome c oxidase subunit III (COX III) of complex IV to ascertain whether other deletions, also flanked by direct repeats, could be equally associated with poor s***m quality. Finally, in order to determine whether multiple mtDNA were indicative of poor s***m quality we employed long PCR. For each of the studies, Percoll-separated leukocyte-extracted s***m samples are studied.

Semen samples were provided by men of proven fertility and patients attending the Assisted Conception Unit, Birmingham Women's Hospital, Birmingham, and the Infertility Clinic at the Jessop Hospital for Women, UK. Recruitment of both patients and fertile men was in accordance with the HFEA (Human Fertilisation and Embryology Authority (HFEA) Code of Practice. Patients in the study were those diagnosed with idiopathic infertility following physical examination and history taking. All men were aged 25 μm/s and motility II as ≤25 and >5 μm/s. S***m morphology was assessed on Papanicolaou-stained smears at ×1000 magnification using bright field illumination on an Olympus BX40 microscope. Samples with

Address

Upper Hill

Telephone

+254736024638

Website

Alerts

Be the first to know and let us send you an email when Fertility solutions Kenya posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Fertility solutions Kenya:

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram